Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445937 · ClinicalTrials.gov registry record · NA
PARTNER II: Improving Patient and Family Centered Care in Advanced Critical Illness
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 848
- Enrollment target
NCT02445937 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 848 participants.
The verdict
NCT02445937, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 848 participants
- Enrollment target
Study Summary
This is a stepped wedged randomized controlled trial comparing the PARTNER intervention with usual care in 5 Intensive Care Units. The overarching goal of this research project to ensure patient-centered decisions about the use of intensive treatments for patients with advanced critical illness. In a prior project, the investigators developed the PARTNER program (PAiring Re-engineered ICU Teams with Nurse-driven Education and OutReach), a 4-facet, team-based intervention that re-engineers how surrogates are supported in ICUs, including: 1) changing care "defaults" to ensure clinician-family meetings within 48 hours of enrollment and frequently thereafter; 2) protocolized, nurse-administered coaching and emotional support of surrogates before and during clinician-family meetings, 3) increased use of palliative care services for patients with a poor prognosis. The investigators propose to begin deployment of the PARTNER II program in the spring of 2015 enrolling 690 surrogate decision makers in 5 ICUs using a stepped wedge design. The investigators expect to achieve the following project goals: 1. To increase the patient-centeredness of end-of-life decisions, and to increase the quality of clinician-family communication. 2. To decrease the psychological burden on family members acting as surrogates. 3. To reduce total health care costs by decreasing the duration of use of burdensome, invasive treatments at the end of life.
Interventions
- BEHAVIORAL PARTNER II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 848 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2019-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02445937
The ClinicalTrials.gov registry entry for NCT02445937 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 848 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PARTNER II is the first listed.
NCT02445937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02445937 about?
NCT02445937 is a clinical study titled "PARTNER II: Improving Patient and Family Centered Care in Advanced Critical Illness". This is a stepped wedged randomized controlled trial comparing the PARTNER intervention with usual care in 5 Intensive Care Units. The overarching goal of this research project to ensure patient-centered decisions about the use of intensive treatments for patients with advanced critical illness. In ...
What is the current status of trial NCT02445937?
This trial is currently completed. It is a NA study. The enrollment target is 848 participants. The study started on 2015-06-01. Estimated completion is 2019-09-18.
What interventions are being tested in trial NCT02445937?
The interventions under investigation include: PARTNER II (BEHAVIORAL).
Who is sponsoring clinical trial NCT02445937?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.